Abstract: The present invention features transgenic rodent models for HIV, wherein the transgenic rodent or transgenic rodent cell has incorporated into its genome genes encoding a human CD4 receptor and a human chemokine receptor. In particular the invention relates to transgenic rats, or mice characterized by being susceptible to infection with HIV, capable of expressing HIV structural genes, or HIV replication. The transgenic rodent or rodent cell of this invention is useful for studying the molecular basis of HIV infection, replication and pathogenicity, as well as for the testing of agents for new antiviral or vaccine strategies.
Type:
Grant
Filed:
December 23, 1999
Date of Patent:
April 16, 2002
Assignee:
The J. David Gladstone Institutes
Inventors:
Mark A. Goldsmith, Roberto F. Speck, Robert E. Atchison, Oliver Keppler
Abstract: Heart failure following myocardial infarction is treated by administration of an angiotensin II inhibitor for 8-12 weeks, followed by administration of a growth hormone for 1-3 weeks.
Type:
Grant
Filed:
June 4, 1997
Date of Patent:
October 23, 2001
Assignee:
The Regents of the University of California